Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology

Volumn 2, Issue 9, 2007, Pages 827-830

  Subramanian, Janakiraman ^a   Velcheti, Vamsidhar ^a   Gao, Feng ^a   Govindan, Ramaswamy ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c Division of Oncology   (United States)

Author keywords

Never smoker; Non small cell lung cancer; Outcomes; Presentation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MISSOURI; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE;

EID: 34548456318     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318145af79     Document Type: Article

References (34)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Koo LC, Ho JH. Worldwide epidemiological patterns of lung cancer in non smokers. Int J Epidemiol 1990;19:s14-s23.
4. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004;22:1103-1109.
5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132.
6. Herbst RS, Prager D, Hermann R, et al. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2005;23:5892-5899.
7. Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005;366:1527-1537.
8. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
9. Gazdar AF. Lung cancer in never smokers - a different pathway. In MC Perry (Ed.), American Society of Clinical Oncology Educational Book. Alexandria, VA: American Society of Clinical Oncology, 2005. Pp 619-621.
10. Ahrendt SA, Decker PA, Alawi EA, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 2001;92:1525-1530.
11. Hashimoto T, Tokuchi Y, Hayashi M, et al. Different subtypes of human lung adenocarcinoma caused by different etiological factors: evidence from p53 mutational spectra. Am J Pathol 2000;157:2133-2141.
12. Hainaut P, Olivier M, Pfeifer GP. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis 2001;16:551-553.
13. Wong MP, Lam WK, Wang E, et al. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. Cancer Res 2002;62:4464-4468.
14. Toyooka STT, Adi F. Gazdar: the TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003;21:229-239.
15. Shinichi Toyooka RM, Kiyomi O, Toyooka Dale McLerran, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003;103:153-160.
16. Wong MP, Lai-Fan Fung, Elaine Wang, et al. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers. Cancer Epidemiol Biomarkers Prev 2003;97:1263-1270.
17. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-351.
18. Dibble R, Langeburg W, Bair S, et al. Natural history of non-small cell lung cancer in non-smokers. J Clin Oncol 2005;23:7252.
19. Lee E, Wei L, Amato D. Cox-type regression analysis for a large numbers of small groups of correlated failure time observations, in Klein JP, Goel PK (eds): Survival Analysis: State of the Art. Netherlands, Kluwer Academic Publishers, 1992, pp711-743.
20. Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003;4:45-55.
21. Gürsel G, Levent E, Öztürk, et al. Hospital based survey of lung cancer in Turkey, a developing country, where smoking is highly prevalent. Lung Cancer 1998;21:127-132.
22. Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006;24:2245-2251.
23. Lee C, Kang KH, Koh Y, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22.
24. Fontham ET, Correa P, Reynolds P, et al. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA 1994;271:1752-1759.
25. Brownson RC, Alavanja MC, Caporaso N, et al. Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev 1998;20:218-236.
26. Kreuzer M, Kreienbrock L, Müller KM, Gerken M, Wichmann E. Histologic types of lung carcinoma and age at onset. Cancer 1999;85:1958-1965.
27. Kabat GC, Wynder EL. Lung cancer in nonsmokers. Cancer 1984;53:1214-1221.
28. Kubik AK, Zatloukal P, Tomasek L, Petruzelka L. Lung cancer risk among Czech women: a case-control study. Prev Med 2002;34:436-444.
29. Goodgame B, Morgensztern D, Grove L, Govindan R. Non-small cell lung cancer in the new millennium: the effect of FDG-PET on stage distribution J Clin Oncol 2006;18(suppl):7205.
30. Toh C-K, Wong E-H, Lim W-T, et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest 2004;126:1750-1756.
31. Gazdar AF, Shigematsu H, Herz J, et al. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? Trends Mol Med 2004;10:481-486.
32. Powell CA, Spira A, Derti A, et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am J Respir Cell Mol Biol 2003;29:157-162.
33. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001;61:1309-1313.
34. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561-570.